CANCER DRUG DISCOVERY: DIVERSITY GENERATION AND SMART ASSAYS -ADDENDUM NIH GUIDE, Volume 26, Number 22, June 27, 1997 RFA: CA-97-006 P.T. 34 Keywords: Cancer/Carcinogenesis Chemistry, Organic Medicinal Chemistry Chemotherapeutic Agents Drug Design National Cancer Institute The following additional information is provided for RFA CA-97-006, "Cancer Drug Discovery: Diversity Generation and Smart Assays," which appeared in the NIH Guide, Vol. 26, No. 15, May 9, 1997: The Letter of Intent Receipt Date has been changed to July 11, 1997. The Application Receipt Date remains at August 22, 1997. The following section on FUNDS AVAILABLE has been changed to clarify the budget limitations on applications. The NCI has set aside $3.75 million total costs (direct plus facilities and administrative costs) for the first year of funding. The number of awards and level of support is dependent on the receipt of a sufficient number and diversity of applications with high scientific merit. It is expected that most awards will not exceed $950,000 total costs (direct plus facilities and administrative costs) for year one with no more than a 3% per year increase for future years. Exceptionally meritorious applications may be funded at a higher level provided the budget is adequately justified and considered reasonable by peer review. In all cases, budget requests should be carefully justified and commensurate with the needs of the project. Because the nature and scope of the research proposed in response to the RFA may vary, it is anticipated that the size of the awards may vary. It is anticipated that four to five awards will be made for periods up to five years, with the earliest expected award date being April 1, 1998. Although this program is provided for in the financial plans of the NCI, awards pursuant to this RFA are contingent upon the availability of funds for this purpose. INQUIRIES For further information contact: Mary K. Wolpert, Ph.D. Division of Cancer Treatment, Diagnosis and Centers National Cancer Institute 6130 Executive Boulevard, Room 841, MSC 7456 Bethesda, MD 20892-7456 Telephone: (301) 496-8783 FAX: (301) 402-5200 Email: wolpertm@dtpepn.nci.nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |